All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Understanding OTC Monograph Reform: Where Do We Stand Now?
By J.P. Borneman, Ph.D. and Alvin J. Lorman, J.D. The FDA’s Over-the-Counter Drug Review (OTC Review) has always been important to homeopathy, despite the fact...
Adulterants in Your Botanical Source Materials – How Do You Know?
By Eric L. Foxman, R.Ph Many commercially available botanical products have been adulterated prior to their introduction to the market. This is a problem that...
Homeopaths Without Borders Helps Haiti
Homeopaths Without Borders (HWB) has led 24 service trips to Haiti since 2010. With the help of volunteer homeopaths, individual donors, and homeopathic organizations and...
Webinar Review: FDA’s View on Compliance
On May 24, 2016, the American Association of Homeopathic Pharmacists hosted the latest in its Compliance through Education webinar series. The webinar featured a presentation...
FDA Guidance for Industry – Request for Quality Metrics
By Mark Land, AAHP President FDA published its draft guidance, Request for Quality Metrics; Guidance for Industry1. Advancing the background on the initiative in general,...
Homeopathic Drug Labels: Rx or OTC?
By J.P. Borneman, Ph.D. and Alvin J. Lorman Homeopathic drugs, we proudly tell folks, really are drugs: the Federal Food, Drug, and Cosmetic Act has...
Do Your Dosage Forms Appeal to Consumers?
By Eric L. Foxman, R.Ph. Consumers make purchase decisions based on several factors such as packaging and perceived effectiveness. Research shows dosage forms also factor...